[Dermatitis caused by estrogens].
BACKGROUND
We report a case of sensitization to estrogen.


METHODS
A 40-year-old woman consulted for skin disorders which followed a cyclic pattern. At each menses, the patient developed pruritus and erythematous papulovesicular lesions over the members and trunk. Estraderm patch contact dermatitis was evident. Prick and patch tests with alcoholic solutions of estrone alone were positive. Serum tests were positive for anti-ethinyl-estradiol antibodies and anti-progesterone antibodies.


CONCLUSIONS
Autoimmune dermatitis can be caused by sensitization to endogenous or exogenous sex hormones. Clinical manifestations and histological findings are variable and non-specific. The cyclic nature of the manifestations is however quite suggestive. Positive prick and patch tests performed with alcohol solutions of the hormones may give the diagnosis and serum tests may be positive for specific anti-steroid antibodies. These complementary explorations are however difficult to perform and interpret and definitive diagnosis is based on an association of clinical findings, skin tests, laboratory tests and the clinical course. In case of progesterone sensitization, the treatment of choice is estrogen inhibition of ovulation. For estrogen sensitization, anti-estrogen treatment appears to be more effective. Finally, bilateral ovariectomy may be required in difficult cases.
Coustou
D
D
Service de Dermatologie, Hôpital Pellegrin, CHU Bordeaux.
Gautier
C
C
Ducombs
G
G
Barbaud
A
A
Geniaux
M
M
D000279:Administration, Cutaneous; D000328:Adult; D001327:Autoimmune Diseases / Q000139:chemically induced / Q000175:diagnosis; D003875:Drug Eruptions / Q000209:etiology*; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D004970:Estrone / Q000008:administration & dosage / Q000009:adverse effects*; D004997:Ethinyl Estradiol / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007428:Intradermal Tests; D010328:Patch Tests; D011374:Progesterone / Q000008:administration & dosage / Q000009:adverse effects*
D004970:Estrone; D004997:Ethinyl Estradiol; D011374:Progesterone